Digital Stress Management in Cancer: Testing StressProffen in a 12-Month Randomized Controlled Trial by Børøsund, Elin et al.
University of Kentucky 
UKnowledge 
Behavioral Science Faculty Publications Behavioral Science 
12-2-2021 
Digital Stress Management in Cancer: Testing StressProffen in a 
12-Month Randomized Controlled Trial 
Elin Børøsund 
Oslo University Hospital, Norway 
Shawna L. Ehlers 
Mayo Clinic 
Matthew M. Clark 
Mayo Clinic 
Michael A. Andrykowski 
University of Kentucky, mandry@uky.edu 
Milada Cvancarova Småstuen 
Oslo Metropolitan University, Norway 
See next page for additional authors 
Follow this and additional works at: https://uknowledge.uky.edu/behavsci_facpub 
 Part of the Behavior and Behavior Mechanisms Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Repository Citation 
Børøsund, Elin; Ehlers, Shawna L.; Clark, Matthew M.; Andrykowski, Michael A.; Cvancarova Småstuen, 
Milada; and Solberg Nes, Lise, "Digital Stress Management in Cancer: Testing StressProffen in a 12-Month 
Randomized Controlled Trial" (2021). Behavioral Science Faculty Publications. 74. 
https://uknowledge.uky.edu/behavsci_facpub/74 
This Article is brought to you for free and open access by the Behavioral Science at UKnowledge. It has been 
accepted for inclusion in Behavioral Science Faculty Publications by an authorized administrator of UKnowledge. 
For more information, please contact UKnowledge@lsv.uky.edu. 
Digital Stress Management in Cancer: Testing StressProffen in a 12-Month 
Randomized Controlled Trial 
Digital Object Identifier (DOI) 
https://doi.org/10.1002/cncr.34046 
Notes/Citation Information 
Published in Cancer. 
© 2021 The Authors 
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-
NoDerivs License, which permits use and distribution in any medium, provided the original work is 
properly cited, the use is non-commercial and no modifications or adaptations are made. 
Authors 
Elin Børøsund, Shawna L. Ehlers, Matthew M. Clark, Michael A. Andrykowski, Milada Cvancarova 
Småstuen, and Lise Solberg Nes 
This article is available at UKnowledge: https://uknowledge.uky.edu/behavsci_facpub/74 
1Cancer  Month 0, 2021
Original Article
Digital stress management in cancer: Testing StressProffen in a 
12- month randomized controlled trial
Elin Børøsund, PhD 1; Shawna L. Ehlers, PhD 2; Matthew M. Clark, PhD 2; Michael A. Andrykowski, PhD 3;  
Milada Cvancarova Småstuen, PhD 4; and Lise Solberg Nes, PhD 1,2,5
BACKGROUND: Cognitive- behavioral stress management interventions are associated with improved psychological well- being for can-
cer survivors. The availability of, access to, and outreach of these in- person interventions are limited, however. The current study, there-
fore, evaluated the efficacy of StressProffen, a digital application (app)– based stress management intervention for cancer survivors, in a 
12- month randomized controlled trial. METHODS: Cancer survivors 1 year or less after their treatment (N = 172) were randomized to the 
StressProffen intervention (n = 84) or a usual- care control group (n = 88). The intervention was delivered in a simple blended care model: 
1) 1 in- person introduction session, 2) 10 app- based cognitive- behavioral stress management modules, and 3) 2 follow- up phone calls. 
Stress (Perceived Stress Scale), anxiety and depression (Hospital Anxiety and Depression Scale), self- regulatory fatigue (Self- Regulatory 
Fatigue 18), and health- related quality of life (HRQOL; RAND- 36) were examined at the baseline and at 6 and 12 months. Generalized 
linear models for repeated measures were fitted to compare effects over time. RESULTS: Participants were mainly female (82%), had 
a mean age of 52 years (standard deviation, 11.3 years; range, 20- 78 years), and had a variety of cancer types (mostly breast cancer 
[48%]). Over the 12- month study time, the intervention group reported significantly decreased stress (P < .001), depression (P =  .003), 
and self- regulatory fatigue (P = .002) as well as improved HRQOL (for 6 of 8 domains, P ≤ .015) in comparison with controls. The largest 
favored effects for the intervention group were observed at 6 months: stress (estimated mean difference [MD], – 5.1; P < .001), anxiety 
(MD, – 1.4; P = .015), depression (MD, – 2.1; P < .001), self- regulatory fatigue (MD, – 4.9; P < .001), and HRQOL (7 of 8 domains; P ≤ .037). 
CONCLUSIONS: Digital stress management interventions such as StressProffen have the potential to extend the outreach of psychologi-
cal interventions and provide easily available and effective psychosocial support for cancer survivors. Cancer 2021;0:1-10. © 2021 The 
Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society This is an open access article under the terms 
of the Creat ive Commo ns Attri butio n- NonCo mmerc ial- NoDerivs License, which permits use and distribution in any medium, provided 
the original work is properly cited, the use is non- commercial and no modifications or adaptations are made. 
KEYWORDS: cancer survivors, cognitive behavioral, electronic health (eHealth), mobile applications, psychological distress, psycho- 
oncology, stress management.
INTRODUCTION
Cancer diagnosis and treatment are associated with physical and psychosocial challenges, including discomfort, fatigue, 
pain, stress, distress, worry, anxiety, and depression.1- 3 Quality of life (QOL)1- 6 and the capacity to control or alter 
(ie, self- regulate) thoughts, feelings, and behavior7,8 are often also affected, and coping during and after cancer can be 
challenging.3,5,8,9
Psychosocial Interventions for Stress Management and Coping in Cancer
Psychosocial interventions aiming to support stress management and coping have for decades been shown to promote 
well- being, including improved QOL and reduced stress, distress, anxiety, and depression for cancer survivors.2,4,5,10- 15 
There are also some indications that the positive impact of such interventions may last for more than 10 years.16
Access barriers to in- person psychological interventions exist, however; they include availability, the geographical 
distance from the intervention site, costs/limited insurance coverage, and cancer survivors not feeling well enough or 
comfortable enough to participate in in- person sessions.5,15 In light of continued findings that cancer survivors have 
many unmet needs, including needs for psychosocial support and care,5,17 health care delivery methods with higher 
accessibility and outreach are needed.
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Digital Psychosocial Interventions for Stress 
Management in Cancer
Digital solutions in the form of electronic health (eHealth) 
interventions have the potential to enhance the delivery of 
health care and psychosocial support to cancer survivors. 
However, published results from randomized controlled 
trials (RCTs) testing psychosocial eHealth interventions 
for cancer survivors are mixed and inconclusive.18- 22 
Examining these findings, researchers have pointed to a 
need for eHealth interventions for cancer survivors to be 
theoretically based; to have significant involvement from 
end users (ie, cancer survivors) and other key stakeholders 
(eg, health care providers) during the design and develop-
ment phases; and to include high- quality outcome assess-
ments, larger sample sizes, and longer follow- up periods 
to establish efficacy.19,20,22
StressProffen: A Digital Stress Management 
Intervention for Cancer Survivors
In response to identified challenges with eHealth inter-
ventions in cancer, the current research team designed 
and developed StressProffen, an application (app)- based 
stress management intervention program in support of 
cancer survivors.23,24 StressProffen combines elements 
from well- known cognitive- behavioral stress management 
strategies4,12,13 and was designed and developed according 
to user- centered design methods with close collaborations 
between researchers, cancer survivors, health care provid-
ers (eg, psychosocial oncologists), and eHealth experts.23 
In line with recommendations to certify the feasibility of 
complex medical interventions,25 a feasibility pilot study 
testing StressProffen revealed positive acceptability, us-
ability, and feasibility, with positive indications related 
to decreased stress, anxiety, and self- regulatory fatigue as 
well as improved health- related quality of life (HRQOL) 
in cancer survivors.24
The initial RCT evaluation of the program (ie, at 
3 months) showed significant pre- post between- group 
diff erences, with cancer survivors who received StressProffen 
reporting decreased stress and improved HRQOL in com-
parison with usual- care controls.26 There was also a de-
crease in anxiety and depression in favor of the intervention 
group, although this was not statistically significant. Effect 
sizes in the 3- month evaluation were generally small, how-
ever, with large data variability, which may have contrib-
uted to this.26 Also, although a 58% completion rate (ie, 
at least 7 of 10 modules26) is considered above average for 
eHealth interventions,27 it is possible that 3 months was 
not enough time for the participating cancer survivors to 
complete the intervention. The current study examined 
longer term results from the RCT and evaluated the efficacy 
of the StressProffen intervention program over a 12- month 
period. It was hypothesized that participants receiving the 
StressProffen intervention, compared with participants in 
a usual- care control group, would 6 and 12 months after 
the intervention initiation experience decreased perceived 
stress (the primary outcome) and decreased anxiety, depres-




In this RCT, participants (ie, cancer survivors) were as-
signed to either 1) the app- based StressProffen stress man-
agement intervention or 2) a usual- care control group and 
were followed for 12 months.
Patients diagnosed with any type or stage of can-
cer were recruited at a major medical center in Northern 
Europe or through social media from June 2017 to July 
2019. The eligibility criteria were 1) currently or recently 
receiving cancer treatment (ie, ≤1 year after the comple-
tion of hospital treatment); 2) being 18 years old or older; 
3) being able to speak, read, and understand Norwegian; 
4) having access to a smartphone or tablet; and 5) being 
able and willing to attend 1 in- person introduction ses-
sion. See also Børøsund and colleagues26 for additional 
details on the study methodology.
The study was approved by the Regional Committee 
for Medical and Health Research Ethics (2016/14369) 
and the Hospital Privacy Protection Committee 
(2015/10204) and was registered with ClinicalTrials.gov 
(NCT02939612).
Study Procedure
Patients were informed about the study via medical 
center social media and/or outpatient clinics/radiother-
apy units, and they could request or self- initiate contact 
with the study team if interested. Participants provided 
written informed consent and completed baseline study 
questionnaires/outcome measures before randomization. 
Computerized randomization allocated study arms on a 
1:1 basis (block size, 10) with stratification by gender and 
diagnosis (ie, breast cancer vs all other cancer diagnoses 
on the basis of pilot- study findings).24
All outcome measures and program use data were 
collected electronically through a secure server using an 
encrypted connection. Participants completed outcome 
Digital Stress Management in Cancer/Børøsund et al
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measures at the baseline and at 3 (reported elsewhere),26 
6, and 12 months.
The StressProffen Intervention
In a simple blended care delivery model, the intervention 
group received the following: 1) an in- person introduc-
tion session with study personnel, 2) 10 app- based stress 
management modules (ie, StressProffen), and 3) follow-
 up phone calls 2 to 3 and 6 to 7 weeks after the introduc-
tion session. The introduction session was structured and 
served the dual purpose of introducing participants to the 
stress management concept1,10,12 and helping participants 
to download and get started with the program.
The StressProffen program contains 10 modules 
with cognitive- behavioral and stress management educa-
tional material and exercises: 1) What is Stress; 2) Stress, 
QOL, and Planning; 3) Thoughts, Feelings, and Self- 
Care; 4) Mindfulness, Thought Challenging, and Guided 
Imagery; 5) Stress and Coping; 6) Social Support, Humor, 
and Meditation; 7) Anger Management and Conflict 
Style Awareness; 8) Assertiveness and Communication; 
9) Health Behaviors and Setting Goals; and 10) Review 
and Summary.23 See Figure 1 for examples of program 
screenshots. For more details about the content, develop-
ment, and pilot testing of StressProffen, see Børøsund and 
colleagues.23,24
Participants were encouraged to complete all 10 
modules and to practice the content to become well ac-
quainted with the material. The follow- up phone calls 
were conducted by study personnel, structured, and in-
cluded questions related to program impression and ease 
of use.
Data Collection and Outcome Measures
A study- specific self- report questionnaire collected demo-
graphic, disease, and treatment information at the base-
line. Comorbidity was measured at the baseline with the 
Self- Administered Comorbidity Questionnaire,28 with 
total scores ranging from 0 to 57 and higher scores indi-
cating a more severe comorbidity profile.
Psychosocial Outcome Measures
Primary outcome
Perceived stress was measured by the Perceived Stress 
Scale, a 14- item scale measuring feelings and thoughts 
over the last month.29 Items are rated on a 5- point Likert 
scale ranging from “never” (0) to “very often” (4). Total 
scores range from 0 to 56, with higher scores indicat-
ing higher perceived stress. Because it is not a diagnostic 
measure, the Perceived Stress Scale has no cutoff scores 
(ie, scores are labeled low, moderate, or high).
Secondary outcomes
Anxiety and depression were measured with the Hospital 
Anxiety and Depression Scale,30 a 14- item measure of 
anxiety and depression, with 7 items measuring each 
subscale. Items are rated on a 4- point scale (0- 3), with 
total scores ranging from 0 to 42 and with higher scores 
Figure 1. Examples of StressProffen screenshots.
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indicating higher anxiety/depression. Score ranges are <8 
(nonclinical), 8 to 11 (indicating the presence of anxiety/
depression), and >11 (anxiety/depression). Nevertheless, 
there are some indications suggesting that these cutoff 
levels are too high for patients with cancer, and this may 
result in underrecognition of distress.31
Self- regulatory fatigue was measured with the Self- 
Regulatory Fatigue 18 (SRF- 18), an 18- item self- report 
scale gauging the capacity to regulate cognitive, emo-
tional, and behavioral components of self- regulation.32 
The SRF- 18 contains 8 positively phrased items (eg, 
“I have no trouble making decisions”) and 10 negatively 
phrased items (eg, “I experience uncontrollable temper 
outbursts”). Items are scored on a 5- point Likert scale (1- 5), 
with total scores ranging from 18 to 90 and with higher 
scores reflecting higher self- regulatory fatigue. The SRF- 
18 has acceptable internal consistency and reliability.32
HRQOL was measured with the 36- Item Short 
Form Health Survey (RAND- 36 version),33,34 a 36- item 
measure of physical, role, emotional, cognitive, and so-
cial function as well as physical health and general and 
global health/HRQOL. Subscale scores range from 0 
to 100, with lower scores indicating higher disability 
(0 = maximum disability, 100 = no disability). A mean of 
50 is generally considered normative for all subscales. The 
normative mean for the general Norwegian population 
may, however, be somewhat higher.35
Program Use
Data related to program use (ie, app progress/activity) 
were extracted from user logs automatically collected and 
stored on a secure research server.
Statistical Analyses
Baseline characteristics are summarized as means and 
standard deviations for normally distributed variables and 
as medians and ranges for variables with skewed distribu-
tions. Categorical data are presented as counts and per-
centages. For the analysis of between- group differences 
in outcome measurements, generalized linear models 
(GLMs) for repeated measures were fitted. To account 
for statistical dependencies as each individual was meas-
ured several times and time spans between the completed 
measurements varied, an unstructured covariance matrix 
was used to model variances. Models for each outcome 
consisted of 3 covariates: measurement (time), group, and 
interaction term (ie, time and group). All measured time 
points (ie, for outcome variables) were considered, and 
the GLM approach was, therefore, adjusted for baseline 
differences.
Because no statistically significant differences were 
observed between the intervention group and the usual- 
care control group in demographic- and disease- related 
variables at the baseline, no covariates were included 
in the GLMs. Outcome analyses were conducted with 
intention- to- treat analyses; all participants in each group 
were included independently of how much they had used 
the intervention. Between- group differences were com-
puted as the intervention group change from the baseline 
to 6 and 12 months minus the control group change from 
the baseline.
Participants completing at least 70% of the mod-
ules (7 of 10) were defined as program completers.24,26 
Exploratory subanalyses for the intervention group only, 
using GLMs, were performed to detect potential differ-
ences in outcomes between intervention completers and 
noncompleters.
P values < .05 were considered statistically sig-
nificant. Statistical analyses were completed with the 
Statistical Package for the Social Sciences (release 27; 
SPSS, Inc, Chicago, Illinois) and Stata (version 16).
RESULTS
Sample Description
Among the 175 randomized participants, 3 intervention 
group assignees were unable to attend the in- person intro-
duction session because of disease progression. The size of 
the final study sample was, therefore, 172. See Figure 2 
for recruitment and retention details. Most participants 
were recruited by medical center clinic staff (102 of 172; 
59%); the remainder were recruited through social media.
The mean age at inclusion was 52 years (standard 
deviation, 11.3 years; range, 20- 78 years). The most 
common cancer type reported was breast cancer (48%). 
Most participants were female (82%), were married or 
cohabitating (70%), reported having a university/college 
education (81%), and were currently receiving sick leave/
disability benefits (70%). See Table 1 for details.
Between- Group Differences
Including measurements from all time points in the 
model showed statistically significant reductions in per-
ceived stress, depression, and self- regulatory fatigue and 
improvements in 6 of 8 HRQOL domains over the 
12- month study period for the StressProffen intervention 
group in comparison with the usual- care control group. 
See Table 2 and Figure 3 for details.
For all outcome measures, the largest intervention 
effects in favor of the intervention group were observed 
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at 6 months. Between- group changes from the baseline to 
6 months were statistically significant and showed that 
the intervention group improved on perceived stress, 
anxiety, depression, self- regulatory fatigue, and 7 of 8 
HRQOL domains in comparison with the usual- care 
control group. See Table 2 for details.
Program Use
Of the 84 participants in the intervention group, 57 
(68%) completed at least 7 of the 10 modules within 
the 12- month study period. Thirty- nine (46%) com-
pleted all 10 modules. There were no significant dif-
ferences in outcomes between intervention completers 
(ie, ≥7 modules) and noncompleters (ie, ≤6 modules). 
Participants used the program a median of 17.5 times 
(range, 3- 170 times), and the median time from first 
use to last use was 137 days (range, 10- 365 days). At 
6 months, 40% (34 of 84) still used the program. This 
declined to 21% (18 of 84) at 9 months and 12% 
(10 of 84) at 11 months.
DISCUSSION
The current study was aimed at evaluating the efficacy 
of StressProffen,23,24,26 a digital cognitive- behavioral 
stress management intervention for cancer survivors. 
The findings demonstrate a significant positive impact 
for the intervention group compared with usual- care 
controls, with between- group differences assessed over 
12 months showing significant reductions in perceived 
stress (ie, the primary outcome) and significant re-
ductions in depression and self- regulatory fatigue and 
Figure 2. Participant trial flow chart.
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significant improvements in HRQOL (ie, the second-
ary outcomes).
Psychosocial interventions can support stress man-
agement and coping for cancer survivors,2,4,5,10- 16 but 
access barriers to such in- person interventions exist.5,15 
Findings from the use of StressProffen in the current 
study, therefore, provide great promise for digital solu-
tions as supplements or alternatives to in- person psy-
chosocial health care for cancer survivors. Even though 
the findings were statistically significant over time, more 
research is needed to explore the potential reasons why 
the largest intervention effects appeared around the 
6- month follow- up. One explanation could be that psy-
chosocial interventions have the most impact at an early 
stage in the cancer survivorship journey when the con-
tent is still new. If this was the case, however, findings 
at 3 months26 could have been expected to be the most 
significant. Because participants were “on their own” 
progressing in the app (ie, it was user- driven rather than 
driven by provider guidance), however, it could be that 
3 months was not enough time and that the 6- month fol-
low- up revealed the benefits of more thoroughly acquired 
knowledge, skills, and strategies. A somewhat larger at-
trition rate in the intervention group compared with the 
control group from 3 to 6 months could potentially also 
have played a role if, for example, mainly particularly 
interested participants remained in the intervention at 
6 months. Another factor to consider is that although both 
groups appeared to improve somewhat from the baseline 
to 3 months, the intervention group continued to im-
prove, whereas the usual- care control group appeared to 
experience worsening symptoms from 3 to 6 months. It 
is possible that cancer survivors in the intervention group 
did in fact experience a sort of buffering effect from the 
StressProffen intervention during what may have other-
wise been a challenging period in the cancer trajectory for 
most participants.
The simple blended care delivery model (ie, 1 intro-
duction session, 10 app- based modules, and 2 follow- up 
phone calls) was used not only to ensure assistance should 
participants encounter technical issues but also to pro-
vide a sense of support throughout the self- management 
process. Even this simple form of blended care may have 
had an impact because guided eHealth interventions have 
been suggested to have better effects than self- guided in-
terventions.20 There was no follow- up contact between 
the research team and the participants between 6 and 
12 months; if the simple blended care delivery induced 
a sense of guidance, this could have contributed to the 
more significant findings at 6 months. Another reason 
could be that the impact decreased as time progressed, 
and this supports the general notion that most interven-
tions show declining impact over time. It should, how-
ever, be noted that even though a clear decline in program 
use was seen from 6 to 12 months, the impact of the pro-
gram (ie, acquired knowledge and skills) could still be of 
benefit independently of actual app use.
Effect sizes in the current study ranged from small 
(<0.2) to moderate (<0.5). The great variation in data, 
indicating that some participants may have benefited 
more from the intervention than others, may have con-
tributed to the limited study effect sizes. However, small 
TABLE 1. Baseline Self- Reported 








(n = 88) P
Age, mean (SD), y 51.7 (10.5) 52.3 (12.0) .725
Gender, No. (%) .956
Female 69 (82) 72 (82)
Male 15 (18) 16 (18)
Marital status, No. (%) .387
Married/cohabitating 56 (67) 64 (73)
Single/divorced 28 (33) 24 (27)
Education, No. (%) .943
Elementary/high school 17 (20) 16 (18)
University/college for ≤4 y 29 (35) 31 (35)
University/college for >4 y 38 (45) 41 (47)
Household annual income,  
No. (%)a
.629
<€40,000 9 (11) 9 (10)
>€40,000- €60,000 15 (18) 17 (19)
>€60,000- €80,000 5 (6) 11 (13)
>€80,000- €100,000 17 (20) 14 (16)
>€100,000 38 (45) 37 (42)
Employment status, No. (%)b .334
Full- time/part- time work 18 (21) 18 (21)
Sick leave/disability benefits 61 (73) 59 (67)
Retired/other 5 (6) 11 (13)
Treatment, No. (%)c
Surgery 66 (79) 60 (68) .124
Chemotherapy 46 (55) 56 (64) .236
Hormone therapy 21 (25) 23 (26) .864
Radiation 34 (41) 40 (46) .519
Immune therapy 8 (10) 10 (11) .694
Other 10 (12) 14 (16) .449
Diagnosis, No. (%)c
Breast cancer 39 (46) 44 (50) .639
Brain cancer 9 (11) 4 (5) .126
Prostate cancer 6 (7) 4 (5) .467
Other 30 (36) 36 (41) .484
Metastases, No. (%) 12 (14) 11 (13) .731
Months since diagnosis, median 
(range)
7.0 (0.25- 120) 8.5 
(0.25- 240)
.183
Comorbidity, median (range) 3.0 (0- 20) 3.0 (0- 17) .467
Abbreviation: SD, standard deviation.
a€1 is approximately US $1.2 or approximately 10 Norwegian kroner (spring 
2021).
bPercentages do not add up to 100 because of rounding.
cParticipants could have received several treatments.
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to moderate statistical effect sizes are not uncommon for 
psychosocial interventions in cancer and still provide ev-
idence of statistical and clinical significance.11,14 The fact 
that such effect sizes can be achieved with even minimal 
cost and effort via a digital approach further highlights 
the significant potential for the outreach and impact of 
digital self- management interventions.
In addition to the longstanding limited availability 
of and access to psychosocial interventions for cancer sur-
vivors, a failure to meet the psychosocial needs of cancer 
TABLE 2. Effects of StressProffen at 6 and 12 Months: Estimated Means From Generalized Linear Models
Intervention Group 
(n = 84)




P Effect Size β Time- Trend PbM 95% CI M 95% CI MD 95% CI
Perceived stress (PSS- 14) <.001
Baseline 26.7 25.0- 28.5 25.6 23.8- 27.3
6 mo 21.1 19.2- 23.0 25.0 23.2- 26.8 – 5.1 – 7.5 to – 2.7 <.001 0.32
12 mo 21.5 19.6- 23.5 22.7 20.8- 24.5 – 2.3 – 4.8 to 0.1 .063 0.14
Anxiety (HADS- A) .111
Baseline 8.5 7.6- 9.4 8.8 7.9- 9.7
6 mo 6.6 5.6- 7.6 8.3 7.4- 9.2 – 1.4 – 2.5 to – 0.3 .015 0.19
12 mo 6.3 5.3- 7.3 7.5 6.6- 8.5 – 1.0 – 2.1 to 0.2 .101 0.14
Depression (HADS- D) .003
Baseline 5.4 4.6- 6.1 5.0 4.3- 5.7
6 mo 3.5 2.7- 4.3 5.3 4.5- 6.0 – 2.1 – 3.0 to – 1.1 <.001 0.36
12 mo 3.8 3.0- 4.6 4.5 3.8- 5.3 – 1.1 – 2.0 to – 0.1 .033 0.19
Self- regulatory fatigue (SRF- 18) .002
Baseline 52.0 49.7- 54.2 50.5 48.3- 52.2
6 mo 47.0 44.6- 49.3 50.4 48.2- 52.6 – 4.9 – 7.2 to – 2.5 <.001 0.31
12 mo 47.8 45.4- 50.2 48.4 46.1- 50.6 – 2.0 – 4.5 to 0.4 .102 0.13
HRQOL (RAND- 36)
Physical functioning .011
Baseline 72.9 68.4- 77.4 79.2 74.8- 83.6
6 mo 79.4 74.5- 84.2 76.5 72.0- 81.1 9.1 2.9 to 15.4 .004 0.22
12 mo 76.2 71.2- 81.2 79.2 74.6- 84.0 3.2 – 0.3 to 9.6 .335 0.06
Role- physical .001
Baseline 19.9 11.7- 28.2 37.5 29.4- 45.6
6 mo 40.8 31.6- 49.9 33.8 25.5- 42.2 24.5 11.4 to 37.6 <.001 0.29
12 mo 34.4 25.1- 43.8 46.3 37.6- 55.0 5.7 – 7.8 to 19.2 .406 0.06
Bodily pain .004
Baseline 57.5 52.4- 62.8 64.1 59.0- 69.3
6 mo 66.6 60.8- 72.4 59.6 54.3- 64.9 13.6 5.8 to 21.4 .001 0.27
12 mo 59.2 53.3- 65.1 64.4 58.9- 69.9 1.4 – 6.6 to 9.4 .727 0.03
General health .075
Baseline 50.2 45.1- 55.2 55.6 50.6- 60.5
6 mo 52.0 46.6- 57.3 52.1 47.0- 57.1 5.3 – 0.1 to 10.4 .053 0.16
12 mo 49.5 44.1- 54.9 53.9 48.8- 59.0 1.0 – 4.5 to 6.5 .719 0.02
Vitality .001
Baseline 38.9 34.2- 43.6 46.5 41.9- 51.0
6 mo 50.4 45.3- 55.4 46.9 42.2- 52.6 11.1 5.1 to 17.1 <.001 0.28
12 mo 47.4 42.2- 52.5 51.5 46.6- 56.3 3.5 – 2.7 to 9.7 .268 0.09
Social functioning <.001
Baseline 51.8 46.5- 57.1 63.1 57.9- 68.2
6 mo 68.9 63.1- 74.6 63.0 57.7- 68.3 17.1 9.5 to 24.7 <.001 0.34
12 mo 69.9 64.0- 75.8 68.0 62.5- 73.5 13.2 5.3 to 21.0 .001 0.26
Role- emotional .070
Baseline 46.8 37.7- 55.9 52.7 43.7- 61.6
6 mo 64.0 53.9- 74.2 53.7 44.5- 62.9 16.1 1.0 to 31.2 .037 0.16
12 mo 66.4 56.0- 76.8 58.3 48.6- 67.9 14.0 – 1.6 to 29.5 .079 0.14
Mental health .015
Baseline 65.3 61.6- 69.0 66.5 62.9- 70.1
6 mo 74.3 70.3- 78.3 66.7 63.0- 70.4 8.8 3.9 to 13.6 <.001 0.28
12 mo 74.9 70.8- 78.9 70.0 66.2- 73.8 6.1 1.0 to 11.1 .018 0.19
Abbreviations: CI, confidence interval; HADS- A, Hospital Anxiety and Depression Scale– Anxiety; HADS- D, Hospital Anxiety and Depression Scale– Depression; 
HRQOL, health- related quality of life; M, estimated mean; MD, estimated mean difference; PSS- 14, Perceived Stress Scale; SRF- 18, Self- Regulatory Fatigue 18.
Three- month findings have been reported elsewhere (see Børøsund et al26).
aBetween- group differences were computed as the intervention group change from the baseline minus the control group change from the baseline. Negative values 
for PSS- 14, HADS- A, HADS- D, and SRF- 18 and positive values for RAND subscales indicate results in favor of the intervention group.
bInteractions between time and group (eg, a statistically significant P value indicates that the time trajectories were different for the 2 groups).
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survivors during the recent coronavirus disease 2019 pan-
demic,17 a pandemic bringing with it an instant need for 
new ways to deliver care, has also been indicated. Digital 
stress management solutions such as StressProffen may 
contribute to solving, or at least limiting, these types of 
challenges by providing innovative options for the out-
reach of effective psychosocial interventions even during 
challenging times.
To achieve the intended impact of interventions, 
adherence and continued use are vital. With adherence/
completion rates for eHealth interventions sometimes as 
low as 20% to 40% (ie, 60%- 80% attrition), however, the 
potential for intervention evaluation and effect is seriously 
compromised, and adherence and attrition surface as major 
obstacles to the realization of eHealth interventions.21,27,36 
In the current study, as many as 68% of the participants 
could be considered completers (ie, completing ≥7 of 10 
modules within the study period).24,26 Completer status 
did, however, not affect outcomes, and this might indicate 
that even modest use of the StressProffen program could 
potentially have a positive impact.
The current study indicates that even minimal 
blended care models can strengthen delivery and the 
chance of impact. Future research should explore the ex-
tent needed to achieve such an impact. Could 1 phone 
call, or a simple introduction by a health care provider, be 
enough? Also, such explorations could determine whether 
completely user- driven digital self- management programs 
Figure 3. Estimated marginal means of (A) perceived stress (PSS- 14), (B) anxiety (HADS- A), (C) depression (HADS- D), and (D) 
self- regulatory fatigue (SRF- 18) for the intervention group (n = 84) and the usual- care control group (n = 88). Higher scores are 
indications of higher levels of stress, anxiety, depression, and self- regulatory fatigue. HADS- A indicates Hospital Anxiety and 
Depression Scale– Anxiety; HADS- D, Hospital Anxiety and Depression Scale– Depression; PSS- 14, Perceived Stress Scale; SRF- 18, 
Self- Regulatory Fatigue 18.
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can be effective; if so, this could mean even more simple, 
cost- effective health care. Future studies should also aim 
to rigorously compare well- established in- person psycho-
social interventions for cancer survivors with comparable 
digital interventions such as StressProffen.
Limitations
This study has several limitations. First, recruitment al-
lowed for cancer survivors to contact the research team if 
they were interested in participation, and it can be assumed 
that these participants (41%) were particularly motivated; 
this potentially affected study generalizability. Second, 
disease status and treatment status were self- reported 
and could not be verified. Third, although a wide variety 
of cancer diagnoses were included in the current study, 
participants were mainly female, with a majority being 
breast cancer survivors. To strengthen generalizability and 
clinical utility, future research should aim to improve the 
gender balance and include more heterogeneous cancer 
survivor populations. Fourth, baseline scores were low to 
moderate for the majority of the outcome measures in the 
current study. It is possible that enrolling cancer survivors 
with higher baseline distress levels (ie, minimal distress 
score inclusion criteria) could have resulted in even higher 
intervention benefits for the participants. Finally, because 
of the access/not- access nature of the intervention, group 
allocation could not be blinded. Intervention group par-
ticipants may, therefore, have anticipated potential effects, 
particularly if they were aware of findings from existing 
StressProffen publications.24,26
In conclusion, in an RCT, cancer survivors receiving 
StressProffen, a digital cognitive- behavioral stress man-
agement intervention delivered in a simple blended care 
model, compared with usual- care cancer survivor controls, 
reported improvements in perceived stress, depression, 
self- regulatory fatigue, and HRQOL over a 12- month 
time period. Digital stress management interventions 
such as StressProffen, built on evidence, with significant 
stakeholder involvement in the design and development 
process, have the potential to improve outreach and pro-
vide easily available and effective psychosocial support for 
cancer survivors. This type of care model could be espe-
cially effective in meeting distress management guidelines 
and accreditation standards in the provision of compre-
hensive cancer care.
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